Joel E. Abelson serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, Joel E. Abelson has executed 13 insider transactions totaling $4.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2011 involved selling 8,810 shares valued at $0.
Joel E. Abelson currently holds 10,278 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel E. Abelson has been a net seller of TLCR stock. They have purchased $0 and sold $4.6M worth of shares.
Joel E. Abelson's most recent insider trade was on Jun 1, 2011, when they sold 8,810 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2011 | TLCR | $39.5K | Payment | 1,468 | $26.94 | Discretionary |
| Feb 1, 2011 | TLCR | $165.0K | Option Exercise | 15,000 | $11.00 | Discretionary |
| Feb 1, 2011 | TLCR | $365.7K | Sale | 15,000 | $24.38 | Discretionary |
| Jan 3, 2011 | TLCR | $495.0K | Option Exercise | 45,000 | $11.00 | Discretionary |
| Jan 3, 2011 | TLCR | $1.0M | Sale | 45,000 | $23.08 | Discretionary |
| Oct 1, 2010 | TLCR | $684.6K | Sale | 30,000 | $22.82 | Discretionary |
| Oct 1, 2010 | TLCR | $330.0K | Option Exercise | 30,000 | $11.00 | Discretionary |
| Aug 27, 2010 | TLCR | $179.5K | Sale | 8,128 | $22.09 | Discretionary |
| Aug 25, 2010 | TLCR | $2.3M | Sale | 105,440 | $21.89 | Discretionary |
| Aug 25, 2010 | TLCR | $1.2M | Option Exercise | 105,440 | $11.00 | Discretionary |
| Sep 30, 2009 | TLCR | $0 | Award | 5,921 | $N/A | Discretionary |